Barbara Burtness – författare
Visar alla böcker från författaren Barbara Burtness. Handla med fri frakt och snabb leverans.
5 produkter
Molecular Determinants of Head and Neck Cancer
Av Erica A. Golemis, Barbara Burtness
E-bok, 2014
2006 kr
Lägg i varukorg
Squamous cell cancers of the head and neck (SCCHN), also known as head and neck cancers (HNC) encompass malignancies of the oral cavity, larynx, nasopharynx and pharynx, and are diagnosed in over 500,000 patients worldwide each year, accounting for 5% of all malignancies. In the past several years, …
Molecular Determinants of Head and Neck Cancer
Av Barbara Burtness, Erica A. Golemis
Häftad, 2018
1692 kr
Lägg i varukorg
Squamous cell cancers of the head and neck (SCCHN), also known as head and neck cancers (HNC) encompass malignancies of the oral cavity, larynx, nasopharynx and pharynx, and are diagnosed in over 500,000 patients worldwide each year, accounting for 5% of all malignancies. It is estimated that …
Molecular Determinants of Head and Neck Cancer
Av Barbara Burtness, Erica A. Golemis
Inbunden, 2018
1692 kr
Lägg i varukorg
Squamous cell cancers of the head and neck (SCCHN), also known as head and neck cancers (HNC) encompass malignancies of the oral cavity, larynx, nasopharynx and pharynx, and are diagnosed in over 500,000 patients worldwide each year, accounting for 5% of all malignancies. It is estimated that …
Molecular Determinants of Head and Neck Cancer
Av Erica A. Golemis, Barbara Burtness
E-bok, 2018
2127 kr
Lägg i varukorg
Squamous cell cancers of the head and neck (SCCHN), also known as head and neck cancers (HNC) encompass malignancies of the oral cavity, larynx, nasopharynx and pharynx, and are diagnosed in over 500,000 patients worldwide each year, accounting for 5% of all malignancies. It is estimated that …
Molecular Determinants of Head and Neck Cancer
Av Barbara Burtness, Erica A. Golemis
Häftad, 2016
2029 kr
Tillfälligt slut
Squamous cell cancers of the head and neck (SCCHN), also known as head and neck cancers (HNC) encompass malignancies of the oral cavity, larynx, nasopharynx and pharynx, and are diagnosed in over 500,000 patients worldwide each year, accounting for 5% of all malignancies. In the past several years, …